This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies
Journal of Translational Medicine Open Access 12 October 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Tawbi, H. A. et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N. Engl. J. Med. 386, 24–34 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidaway, P. LAG3 inhibition improves outcomes. Nat Rev Clin Oncol 19, 149 (2022). https://doi.org/10.1038/s41571-022-00602-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-022-00602-8